MC1R variation and melanoma risk in the Swedish population in relation to clinical and pathological parameters

Pigment Cell and Melanoma Research

Volumn 22, Issue 2, 2009, Pages 196-204

  Höiom, Veronica ^a,d   Tuominen, Rainer ^a   Käller, Max ^b   Lindén, Diana ^a   Ahmadian, Afshin ^b   Månsson Brahme, Eva ^a   Egyhazi, Suzanne ^a   Sjöberg, Klas ^c   Lundeberg, Joakim ^b   Hansson, Johan ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b ROYAL INSTITUTE OF TECHNOLOGY   (Sweden)

^c LUND UNIVERSITY   (Sweden)

^d LingVitae AB ^*  (Sweden)

Author keywords

Association; Dysplastic nevi; MC1R; Melanoma; Phenotype

Indexed keywords

ACRAL LENTIGINOUS MELANOMA; ADULT; AGED; ALLELE; ARTICLE; CANCER PATIENT; CANCER RISK; CDKN2A GENE; CONTROLLED STUDY; DYSPLASTIC NEVUS; FEMALE; GENE; GENETIC VARIABILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MELANOCORTIN 1 RECEPTOR GENE; MELANOMA; NUCLEOTIDE SEQUENCE; PHENOTYPE; POMC GENE; TUMOR LOCALIZATION;

ADULT; AGED; ALLELES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HETEROZYGOTE; HUMANS; MALE; MELANOMA; MIDDLE AGED; MUTATION; ODDS RATIO; PHENOTYPE; RECEPTOR, MELANOCORTIN, TYPE 1; SWEDEN; TUMOR SUPPRESSOR PROTEIN P14ARF;

EID: 62149096757     PISSN: None     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1755-148X.2008.00526.x     Document Type: Article

References (39)

1. Auroy, S., Avril, M.F., Chompret, A. et al. (2001). Sporadic multiple primary melanoma cases: CDKN2A germline mutations with a founder effect. Genes Chromosomes Cancer 32, 195 202.
2. Bastiaens, M.T., ter Huurne, J.A., Kielich, C., Gruis, N.A., Westendorp, R.G., Vermeer, B.J., Bavinck, J.N. Leiden Skin Cancer Study, T. (2001). Melanocortin-1 receptor gene variants determine the risk of nonmelanoma skin cancer independently of fair skin and red hair. Am. J. Hum. Genet. 68, 884 894.
3. Beaumont, K.A., Newton, R.A., Smit, D.J., Leonard, J.H., Stow, J.L. Sturm, R.A. (2005). Altered cell surface expression of human MC1R variant receptor alleles associated with red hair and skin cancer risk. Hum. Mol. Genet. 14, 2145 2154.
4. Beckman, L.E., Sjoberg, K., Eriksson, S. Beckman, L. (2001). Haemochromatosis gene mutations in Finns, Swedes and Swedish Saamis. Hum. Hered. 52, 110 112.
5. Berwick, M., Orlow, I., Hummer, A.J. et al. (2006). The prevalence of CDKN2A germ-line mutations and relative risk for cutaneous malignant melanoma: an international population-based study. Cancer Epidemiol. Biomarkers Prev. 15, 1520 1525.
6. Borg, A., Johannsson, U., Johannsson, O., Hakansson, S., Westerdahl, J., Masback, A., Olsson, H. Ingvar, C. (1996). Novel germline p16 mutation in familial malignant melanoma in southern Sweden. Cancer Res. 56, 2497 2500.
7. Box, N.F., Duffy, D.L., Chen, W., Stark, M., Martin, N.G., Sturm, R.A. Hayward, N.K. (2001). MC1R genotype modifies risk of melanoma in families segregating CDKN2A mutations. Am. J. Hum. Genet. 69, 765 773.
8. Curtin, J.A., Busam, K., Pinkel, D. Bastian, B.C. (2006). Somatic activation of KIT in distinct subtypes of melanoma. J. Clin. Oncol. 24, 4340 4346.
9. Debniak, T., Scott, R.J., Huzarski, T. et al. (2005). CDKN2A common variants and their association with melanoma risk: a population-based study. Cancer Res. 65, 835 839.
10. Fargnoli, M.C., Chimenti, S., Keller, G., Hofler, H. Peris, K. (2003). Identification of four novel melanocortin 1 receptor (MC1R) gene variants in a Mediterranean population. Hum. Mutat. 21, 655.
11. Fitzpatrick, T.B. (1988). The validity and practicality of sun-reactive skin types I through VI. Arch. Dermatol. 124, 869 871.
12. Flanagan, N., Healy, E., Ray, A., Philips, S., Todd, C., Jackson, I.J., Birch-Machin, M.A. Rees, J.L. (2000). Pleiotropic effects of the melanocortin 1 receptor (MC1R) gene on human pigmentation. Hum. Mol. Genet. 9, 2531 2537.
13. Gerstenblith, M.R., Goldstein, A.M., Fargnoli, M.C., Peris, K. Landi, M.T. (2007). Comprehensive evaluation of allele frequency differences of MC1R variants across populations. Hum. Mutat. 28, 495 505.
14. Goldstein, A.M., Chan, M., Harland, M. et al. (2007a). Features associated with germline CDKN2A mutations: a GenoMEL study of melanoma-prone families from three continents. J. Med. Genet. 44, 99 106.
15. Goldstein, A.M., Chaudru, V., Ghiorzo, P. et al. (2007b). Cutaneous phenotype and MC1R variants as modifying factors for the development of melanoma in CDKN2A G101W mutation carriers from 4 countries. Int. J. Cancer 121, 825 831.
16. Gudbjartsson, D.F., Sulem, P., Stacey, S.N. et al. (2008). ASIP and TYR pigmentation variants associate with cutaneous melanoma and basal cell carcinoma. Nat. Genet. 40, 886 891.
17. Hashemi, J., Platz, A., Ueno, T., Stierner, U., Ringborg, U. Hansson, J. (2000). CDKN2A germ-line mutations in individuals with multiple cutaneous melanomas. Cancer Res. 60, 6864 6867.
18. Hashemi, J., Bendahl, P.O., Sandberg, T., Platz, A., Linder, S., Stierner, U., Olsson, H., Ingvar, C., Hansson, J. Borg, A. (2001). Haplotype analysis and age estimation of the 113insR CDKN2A founder mutation in Swedish melanoma families. Genes Chromosomes Cancer 31, 107 116.
19. Helsing, P., Nymoen, D.A., Ariansen, S. et al. (2008). Population-based prevalence of CDKN2A and CDK4 mutations in patients with multiple primary melanomas. Genes Chromosomes Cancer 47, 175 184.
20. Hussussian, C.J., Struewing, J.P., Goldstein, A.M., Higgins, P.A., Ally, D.S., Sheahan, M.D., Clark, W.H. Jr., Tucker, M.A. Dracopoli, N.C. (1994). Germline p16 mutations in familial melanoma. Nat. Genet. 8, 15 21.
21. Jimenez-Cervantes, C., Germer, S., Gonzalez, P., Sanchez, J., Sanchez, C.O. Garcia-Borron, J.C. (2001). Thr40 and Met122 are new partial loss-of-function natural mutations of the human melanocortin 1 receptor. FEBS Lett. 508, 44 48.
22. Käller, M., Touminen, R., Ahmadian, A., Magnusson, V., Egyhazi, S., Hansson, J. Lundeberg, J. (2005). Detection of MC1R polymorphisms with PrASE as an alternative to direct sequencing. Clin. Chem. 51, 2388 2391.
23. Kamb, A., Shattuck-Eidens, D., Eeles, R. et al. (1994). Analysis of the p16 gene (CDKN2) as a candidate for the chromosome 9p melanoma susceptibility locus. Nat. Genet. 8, 23 26.
24. Kennedy, C., ter Huurne, J., Berkhout, M., Gruis, N., Bastiaens, M., Bergman, W., Willemze, R. Bavinck, J.N. (2001). Melanocortin 1 receptor (MC1R) gene variants are associated with an increased risk for cutaneous melanoma which is largely independent of skin type and hair color. J. Invest. Dermatol. 117, 294 300.
25. Krude, H., Biebermann, H., Luck, W., Horn, R., Brabant, G. Gruters, A. (1998). Severe early-onset obesity, adrenal insufficiency and red hair pigmentation caused by POMC mutations in humans. Nat. Genet. 19, 155 157.
26. MacKie, R.M., Andrew, N., Lanyon, W.G. Connor, J.M. (1998). CDKN2A germline mutations in U.K. patients with familial melanoma and multiple primary melanomas. J. Invest. Dermatol. 111, 269 272.
27. Millington, G.W. (2006). Proopiomelanocortin (POMC): the cutaneous roles of its melanocortin products and receptors. Clin. Exp. Dermatol. 31, 407 412.
28. Naysmith, L., Waterston, K., Ha, T., Flanagan, N., Bisset, Y., Ray, A., Wakamatsu, K., Ito, S. Rees, J.L. (2004). Quantitative measures of the effect of the melanocortin 1 receptor on human pigmentary status. J. Invest. Dermatol. 122, 423 428.
29. Palmer, J.S., Duffy, D.L., Box, N.F., Aitken, J.F., O'Gorman, L.E., Green, A.C., Hayward, N.K., Martin, N.G. Sturm, R.A. (2000). Melanocortin-1 receptor polymorphisms and risk of melanoma: is the association explained solely by pigmentation phenotype? Am. J. Hum. Genet. 66, 176 186.
30. Platz, A., Hansson, J., Mansson-Brahme, E., Lagerlof, B., Linder, S., Lundqvist, E., Sevigny, P., Inganas, M. Ringborg, U. (1997). Screening of germline mutations in the CDKN2A and CDKN2B genes in Swedish families with hereditary cutaneous melanoma. J. Natl Cancer Inst. 89, 697 702.
31. Puig, S., Malvehy, J., Badenas, C. et al. (2005). Role of the CDKN2A locus in patients with multiple primary melanomas. J. Clin. Oncol. 23, 3043 3051.
32. Purcell, S., Neale, B., Todd-Brown, K. et al. (2007). PLINK: a tool set for whole-genome association and population-based linkage analyses. Am. J. Hum. Genet. 81, 559 575.
33. Rees, J.L. (2004). The genetics of sun sensitivity in humans. Am. J. Hum. Genet. 75, 739 751.
34. Smith, R., Healy, E., Siddiqui, S. et al. (1998). Melanocortin 1 receptor variants in an Irish population. J. Invest. Dermatol. 111, 119 122.
35. Sturm, R.A. (2002). Skin colour and skin cancer - MC1R, the genetic link. Melanoma Res. 12, 405 416.
36. Sulem, P., Gudbjartsson, D.F., Stacey, S.N. et al. (2007). Genetic determinants of hair, eye and skin pigmentation in Europeans. Nat. Genet. 39, 1443 1452.
37. Valverde, P., Healy, E., Jackson, I., Rees, J.L. Thody, A.J. (1995). Variants of the melanocyte-stimulating hormone receptor gene are associated with red hair and fair skin in humans. Nat. Genet. 11, 328 330.
38. Wennberg, C., Kozlenkov, A., Di Mauro, S., Frohlander, N., Beckman, L., Hoylaerts, M.F. Millan, J.L. (2002). Structure, genomic DNA typing, and kinetic characterization of the D allozyme of placental alkaline phosphatase (PLAP/ALPP). Hum. Mutat. 19, 258 267.
39. Zuo, L., Weger, J., Yang, Q., Goldstein, A.M., Tucker, M.A., Walker, G.J., Hayward, N. Dracopoli, N.C. (1996). Germline mutations in the p16INK4a binding domain of CDK4 in familial melanoma. Nat. Genet. 12, 97 99.